In utero stem cell transplantation is a novel therapy targeted at the fetus, within the uterus early in a pregnancy. This therapy is intended to treat a genetic disorder, diagnosed within the first 12 weeks of gestation, before the pathological effects become manifested. Currently, there are some successful cases reported and European centres are in a leading position in the field. However, there is a pressing need for consensus in many aspects of this therapy and a consortium of European centres with expertise in many areas of stem cells and transplantation will be uniquely placed to ensure that the in utero procedure can be used to maximum benefit.
Funding SchemeCON - Coordination of research actions
BS10 5ND Bristol
171 76 Stockholm
2300 RC Leiden